EULAR, The European Alliance of Associations for Rheumatology, updated its recommendations for systemic sclerosis (SSc) in 2023. Notably, four new therapies were added that had not been included in ...

What is the latest research on scleroderma? Find out in this collection of recent MEDLINE abstracts compiled by the editors at Medscape Nurses. Acute and chronic renal diseases remain common ...

Fibrosis, or the scaring of tissue, occurs in many diseases, and is a central component of systemic sclerosis. There are currently no treatments that can reverse fibrosis and the current treatment ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Patients with systemic sclerosis will likely require multidisciplinary management with combination ...

The drug tofacitinib was well tolerated among patients with early scleroderma, primarily affecting the protein interferon both in fibroblasts and keratinocytes. Researchers say the drug is safe and ...

Systemic sclerosis causes the skin to tighten and harden resulting in a potentially fatal autoimmune condition that is associated with lung fibrosis and kidney disease. University of Michigan Health ...

Please provide your email address to receive an email when new articles are posted on . ACR and the American College of Chest Physicians jointly recommend against glucocorticoids as first-line or long ...

Normally, your immune system fights off disease and protects your body from infection. However, when you have an autoimmune disease, your immune system mistakenly attacks healthy cells, tissues and ...